Random blood sugar levels and pseudocholinesterase levels their relevance in organophosphorus compound poisoning

Ramchander Rao; G. Bala Raju

doi:10.18203/2394-6040.ijcmph20163357

Authors

Ramchander Rao Department of Medicine, Osmania General Hospital, Hyderabad, Telangana, India
G. Bala Raju Department of Medicine, Osmania General Hospital, Hyderabad, Telangana, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20163357

Keywords:

Random blood sugar levels, Pseudocholinesterase levels, Organophosphorus compounds

Abstract

Background: Most of the organophosphates used as the insecticides inhibit both pseudocholinesterase and acetylcholinesterase. Estimation of erythrocyte cholinesterase (acetylcholinesterase) is theoretically preferred, since it would indicate the degree of inhibition of synaptic cholinesterase (also acetyle-cholinesterase). Estimation of plasma cholinesterase (pseudo cholinesterase) has an advantage because the measurement is simpler and more accurate than estimation of erythrocyte cholinesterase.

Methods: We studied fifty cases of organophsphorus poisoning directly admitted in acute medical care of Osmania General Hospital, Hyderabad, India.

Results: Out of fifty patients 26% of the patients had mild depression of serum pseudo cholinesterase levels and 42% of patients had moderate depression of serum cholinesterase levels and 32% of patients showed severe depressions of cholinesterase levels. Mortality rates of 26% were observed in our study, 6% of the patients required ventilatory support and two patients (4%) developed intermediate syndrome. Respiratory paralysis was the major cause of death.

Conclusions: Hyperglycemia at admission correlates with depression of pseudo cholinesterase levels in organophosphorus poisoning. Random blood sugar levels of >200 mg/dl at admission and depression in pseudocholinesterase levels <1000 U/L (p<0.005) are reliable parameters to predict mortality and ventilator requirement in organophosphorus poisoning.

Metrics

Metrics Loading ...

References

Haley TJ, Berndt WO. Toxicology - Published by Taylor & Francis, 1987: 49

Tareg AB. Organophosphate and carbamate insecticides. Clinical environmental health and toxic exposures. SJB and GR Krieger. Philadelphia, Lippincott Williams & Wilkins. 2001;1046-57.

Gannur DG, Maka P, Narayan Reddy KS. Organophasphorous compound poisoning in Gulbarga region –A five year study. Indian J Foensic Med and Toxicology. 2008;2(1) (2008-01 - 2008-06).

Agarwal SB. A clinical, biochemical, neurobehavioral, and sociopsychological study of 190 patients admitted to hospital as a result of acute organophosphorus poisoning. Environmental Res. 1993;62:63-70.

Gohel D, Rayoo R, Nangha P. Clinical profile and Early Cardiotoxicity of Organo Phosphate Compounds Poisoning (A Study of 100 Cases). J Assoc of Physicians of India. 2001;49(1).

Kumar APN, Murthy GL, Rajasekhar L, Prasad AK, Rao MN, Raju YS, Srinivasan VR, Shantaram V. Clinical profile of organophosphate and organocarbamate poisoning. J Assoc Physicians India. 2001;49(1).

Dhadke VN, Kulkarni PM, Inamdar MJ. The clinical profile of organophosphorous compound poisoning. J Assoc Physicians India. 2001;49(1). abstracts from APICON 2001.

Wadia RS. The Neurology of organophasphorus insecticide poisoning Newer findings a view point. J Assoc Physicians India. 1990;38(2):129-30.

Scananayake N, Karalliedde L. Neurotoxic effects of organophosphorus insecticides. An intermediate syndrome. N Engl J Med. 1987;316:761-3.

Mani A, Thomas MS, Abraham AP. Type II Paralysis of Intermediate syndrome following organophasphorous poisoning. J Assoc Physicians India. 1992;40(8):542-4.

Text book of pediatric emergency medicine – Gary R Fleisher, Stephen ludwig, FredM Henretia. 151-152.

Lotti M, Becker CE, Aminoff MJ. Organophosphate Polyneuropathy. Pathogenesis and Prevention. Neurology. 1984;34:658-62.